Tata Elxsi reported operating revenue of ₹1,021.1 crore for the first quarter of FY27, registering a growth of 2.8% quarter-on-quarter and 14.5% year-on-year. The EBITDA stood at ₹216 crore, rising 15.7% YoY, with an EBITDA margin of 21.2% during the quarter.ALSO READ | Tata Elxsi Q4 profit doubles, margin expands; ₹75 dividend declared
The company said growth during the quarter was driven by the Transportation segment, which grew 13.3% YoY, and the Media & Communication segment, which grew 22.2% YoY.
Quarter-on-Quarter
It reported a 22.6% quarter-on-quarter decline in net profit to ₹171 crore for the first quarter, compared with ₹220 crore in the previous quarter. Revenue from operations increased 2.8% QoQ to ₹1,021.1 crore from ₹993.8 crore.
The company’s Earnings Before Interest and Taxes (EBIT) declined 12.5% QoQ to ₹193.7 crore from ₹221.3 crore. The EBIT margin stood at 18.97% in Q1, compared with 22.27% in the previous quarter.
Transportation and Media & Communication segments drive growthManoj Raghavan, CEO and Managing Director, Tata Elxsi, said, “For the quarter, Tata Elxsi delivered a healthy performance with growth in our two primary verticals, supported by strong deal execution and continued momentum in large strategic engagements.
ALSO READ | Tata Elxsi, JSW Motors sign MoU to set up EV tech centre in Pune
We also crossed a key milestone of reporting operating revenue of more than ₹1,000 crores in the current quarter. The performance in the quarter reflects the strength and increasing relevance of our design-led and AI-enabled engineering capabilities in our chosen industries.
Our Transportation business reported a growth of 13.3% YoY, driven by accelerated OEM engagements and strategic wins in the off-road and aerospace segments. We are scaling our offerings and capabilities to help
Auto OEMs pivot to connected, multi-powertrain and AI-powered mobility, with OEM revenues now constituting 78% of our automotive revenues.”
He added, “Our Healthcare and Life Sciences business reported a growth of 1.7% QoQ, amidst a muted business environment for the healthcare industry. We are investing in pivoting to an AI-first, design-led, and regulatory-aware engineering approach in this business, partnering with leading AI companies across the world.
ALSO READ | Tata Elxsi shares drop 4% after Morgan Stanley sharply cuts target on Q4 topline miss
In this quarter, we announced the launch of a Gen AI-powered material intelligence platform, ViTEL, and an AI-native Software Development platform for medtech and healthcare, AnaTEL.”
Shares of Tata Elxsi Ltd ended at ₹3,700.30, down by ₹122.60, or 3.21%, on the BSE.
